Biodegradable botulinum toxin implant
US6506399B2 · kind B2 · utility
634Cited by
24References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 4, 2001 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | Nov 4, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A controlled release system for multiphasic, in vivo release of therapeutic amounts of botulinum toxin in a human patient over a prolonged period of time. The controlled release system can comprise a plurality of botulinum toxin incorporating polymeric microspheres.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.